Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.48 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.48 |
| ▸ | RELA | Q04206 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | CYP11B1 | P15538 | 5/20 | 0.46 |
| ▸ | CYP11B2 | P19099 | 5/20 | 0.46 |
| ▸ | HPGDS | O60760 | 1/20 | 0.46 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.46 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.42 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.42 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12523554 | 0.96 | MAPK1 (0.56) | LDHANPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL15747736 | 0.94 | NPC1 (0.53) | LDHANPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL646630 | 0.89 | CYP2A6 (0.50) | LDHANPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL19933574 | 0.88 | NPC1 (0.52) | LDHANPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL2482041 | 0.86 | HSD17B1 (0.47) | LDHANPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL1416706 | 0.86 | NPC1 (0.55) | NPC1RAB9ANFKB1NFKB2RELA | |
| SCHEMBL9613082 | 0.85 | NPC1 (0.63) | LDHANPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL2251228 | 0.85 | NPC1 (0.63) | LDHANPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL13917369 | 0.84 | HSD17B1 (0.48) | LDHANPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL787234 | 0.83 | CYP11B1 (0.49) | LDHANPC1RAB9ANFKB1NFKB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 494 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111499569-B | Method for simultaneously synthesizing 5-bromo-2-phenylpyridine and 2- (4-bromophenyl) pyridine in one step without metal catalysis | 华中科技大学 | 2021-05-14 | — | — | CN | claimed |
| CN-111499569-A | Method for simultaneously synthesizing 5-bromo-2-phenylpyridine and 2- (4-bromophenyl) pyridine in one step without metal catalysis | 华中科技大学 | 2020-08-07 | — | — | CN | claimed |
| JP-11171863-A | — | — | None | — | — | JP | disclosed |
| EP-4683925-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2026-01-28 | — | — | EP | disclosed |
| US-20260015313-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | PEPTIDREAM INC (JP) | 2026-01-15 | — | — | US | disclosed |
| US-20250353833-A1 | DPP9 BINDING COMPOUNDS | UNIV ANTWERPEN (BE) | 2025-11-20 | — | — | US | disclosed |
| EP-4640022-A1 | MATERIALS FOR ELECTRONIC DEVICES | Merck Patent GmbH (DE) | 2025-10-29 | — | — | EP | disclosed |
| US-20250257035-A1 | 1,4-Substituted Piperidine Derivatives | CEPHALON LLC | 2025-08-14 | — | — | US | disclosed |
| EP-4601449-A2 | COMPOUNDS USABLE AS ACTIVE COMPOUNDS IN AN ORGANIC ELECTRONIC DEVICE | Merck Patent GmbH (DE) | 2025-08-13 | — | — | EP | disclosed |
| US-20250213560-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS HAVING PHENYL GROUP AND USES THEREOF | BNH RESEARCH CO., LTD. (KR) | 2025-07-03 | — | — | US | disclosed |
| EP-4190880-B1 | COMPOUNDS USABLE AS ACTIVE COMPOUNDS IN AN ORGANIC ELECTRONIC DEVICE | MERCK PATENT GMBH (DE) | 2025-07-02 | — | — | EP | disclosed |
| EP-0979226-A1 | ISOXAZOLE DERIVATIVES | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2000-02-16 | — | — | EP | disclosed |
| JP-H11171863-A | PHENYLPYRIDINYLBENZOIC ACID TRIFLUOROALKANOL ESTER AND LIQUID CRYSTAL COMPOSITION | CHISSO CORP | 1999-06-29 | — | — | JP | disclosed |
| WO-1998047880-A1 | ISOXAZOLE DERIVATIVES | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1998-10-29 | — | — | WO | disclosed |
| EP-0517365-B1 | Method and apparatus for silicon nitride precursor solids recovery | FORD MOTOR CO (GB) | 1996-01-31 | — | — | EP | disclosed |
| EP-0674635-A1 | QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHASE INHIBITORS | ZENECA LIMITED (GB) | 1995-10-04 | — | — | EP | disclosed |
| US-5403563-A | Apparatus for silicon nitride precursor solids recovery | FORD MOTOR COMPANY (US) | 1995-04-04 | — | — | US | disclosed |
| WO-1994014803-A1 | QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHASE INHIBITORS | ZENECA LIMITED (GB) | 1994-07-07 | — | — | WO | disclosed |
| US-5171557-A | METHOD FOR SILICON NITRIDE PRECURSOR SOLIDS RECOVERY | FORD MOTOR COMPANY (US) | 1992-12-15 | — | — | US | disclosed |
| EP-0517365-A1 | Method and apparatus for silicon nitride precursor solids recovery | FORD MOTOR COMPANY LIMITED (GB) | 1992-12-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250257035-A1 | 1,4-Substituted Piperidine Derivatives | FASN, CES1, CPT1A | LDHA 3251/4885NPC1 198/4885RAB9A 2624/4885 |
| US-20260015313-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | NSUN3, BCAT1, SLC43A1 | LDHA 1324/4885NPC1 1159/4885RAB9A 1211/4885 |
| US-20250213560-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS HAVING PHENYL GROUP AND USES THEREOF | PNMT, BDNF, NLN | LDHA 1400/4885NPC1 1087/4885RAB9A 1763/4885 |
| US-20250353833-A1 | DPP9 BINDING COMPOUNDS | DPP9, DPP7, DPP3 | LDHA 865/4885NPC1 1617/4885RAB9A 1580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.